This Article Full Text Full Text (PDF) Other Versions of this Article: MCB.01394-06v1 27/1/324    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhu, Q. Articles by Luo, K. Search for Related Content PubMed PubMed Citation Articles by Zhu, Q. Articles by Luo, K.

Dual Role of SnoN in Mammalian Tumorigenesis

Department of Molecular and Cell Biology, University of California, Berkeley,¹ Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720,² Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, Texas 78229-3900³

Received 28 July 2006/ Returned for modification 19 September 2006/ Accepted 16 October 2006

SnoN is an important negative regulator of transforming growth factor ß signaling through its ability to interact with and repress the activity of Smad proteins. It was originally identified as an oncoprotein based on its ability to induce anchorage-independent growth in chicken embryo fibroblasts. However, the roles of SnoN in mammalian epithelial carcinogenesis have not been well defined. Here we show for the first time that SnoN plays an important but complex role in human cancer. SnoN expression is highly elevated in many human cancer cell lines, and this high level of SnoN promotes mitogenic transformation of breast and lung cancer cell lines in vitro and tumor growth in vivo, consistent with its proposed prooncogenic role. However, this high level of SnoN expression also inhibits epithelial-to-mesenchymal transdifferentiation. Breast and lung cancer cells expressing the shRNA for SnoN exhibited an increase in cell motility, actin stress fiber formation, metalloprotease activity, and extracellular matrix production as well as a reduction in adherens junction proteins. Supporting this observation, in an in vivo breast cancer metastasis model, reducing SnoN expression was found to moderately enhance metastasis of human breast cancer cells to bone and lung. Thus, SnoN plays both protumorigenic and antitumorigenic roles at different stages of mammalian malignant progression. The growth-promoting activity of SnoN appears to require its ability to bind to and repress the Smad proteins, while the antitumorigenic activity can be mediated by both Smad-dependent and Smad-independent pathways and requires the activity of small GTPase RhoA. Our study has established the importance of SnoN in mammalian epithelial carcinogenesis and revealed a novel aspect of SnoN function in malignant progression.

Published ahead of print on 30 October 2006.

This article has been cited by other articles:

• Le Scolan, E., Zhu, Q., Wang, L., Bandyopadhyay, A., Javelaud, D., Mauviel, A., Sun, L., Luo, K. (2008). Transforming Growth Factor-{beta} Suppresses the Ability of Ski to Inhibit Tumor Metastasis by Inducing Its Degradation. Cancer Res. 68: 3277-3285 [Abstract] [Full Text]  
• Wilkinson, D. S., Tsai, W.-W., Schumacher, M. A., Barton, M. C. (2008). Chromatin-Bound p53 Anchors Activated Smads and the mSin3A Corepressor To Confer Transforming Growth Factor {beta}-Mediated Transcription Repression. Mol. Cell. Biol. 28: 1988-1998 [Abstract] [Full Text]  
• Levy, L., Howell, M., Das, D., Harkin, S., Episkopou, V., Hill, C. S. (2007). Arkadia Activates Smad3/Smad4-Dependent Transcription by Triggering Signal-Induced SnoN Degradation. Mol. Cell. Biol. 27: 6068-6083 [Abstract] [Full Text]  
• Nagano, Y., Mavrakis, K. J., Lee, K. L., Fujii, T., Koinuma, D., Sase, H., Yuki, K., Isogaya, K., Saitoh, M., Imamura, T., Episkopou, V., Miyazono, K., Miyazawa, K. (2007). Arkadia Induces Degradation of SnoN and c-Ski to Enhance Transforming Growth Factor-beta Signaling. J. Biol. Chem. 282: 20492-20501 [Abstract] [Full Text]